COLORECTAL TUMORS

Clinical trials for COLORECTAL TUMORS explained in plain language.

Never miss a new study

Get alerted when new COLORECTAL TUMORS trials appear

Sign up with your email to follow new studies for COLORECTAL TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1 Completed 1 Terminated 1

New combo attack targets hard-to-treat KRAS G12C cancers

Disease control Ongoing

This study tests a new drug called JDQ443, which targets a specific cancer-driving mutation (KRAS G12C), in combination with other drugs (trametinib, ribociclib, or cetuximab). The trial enrolls about 74 people with advanced solid tumors (like lung or colorectal cancer) that have…

Matched conditions: COLORECTAL TUMORS

Phase: PHASE1, PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control

Last updated Jun 27, 2026 14:00 UTC

COLORECTAL TUMORS

Get alerted when new COLORECTAL TUMORS trials appear

New combo attack targets hard-to-treat KRAS G12C cancers